Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeline R Meirhaeghe

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 15, 2025
Epstein-Barr virus (EBV) infection and its sequelae in the immunocompetent hostMadeline R Meirhaeghe, Henry H Balfour
Current Topics in Microbiology and Immunology|August 8, 2025
Infectious MononucleosisHenry H Balfour, Madeline R Meirhaeghe
Virology|May 29, 2026
The rationale for universal use of a prophylactic Epstein-Barr virus vaccineMadeline R Meirhaeghe, Henry H Balfour
Vaccines|September 23, 2022
Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV VaccineHenry H Balfour, Madeline R Meirhaeghe, Arianna L Stancari, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 25, 2022
Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infectionJennifer M Geris, Arianna L Stancari, Madeline R Meirhaeghe, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 15, 2025
Epstein-Barr virus (EBV) infection and its sequelae in the immunocompetent hostMadeline R Meirhaeghe, Henry H Balfour
Current Topics in Microbiology and Immunology|August 8, 2025
Infectious MononucleosisHenry H Balfour, Madeline R Meirhaeghe
Virology|May 29, 2026
The rationale for universal use of a prophylactic Epstein-Barr virus vaccineMadeline R Meirhaeghe, Henry H Balfour
Vaccines|September 23, 2022
Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV VaccineHenry H Balfour, Madeline R Meirhaeghe, Arianna L Stancari, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 25, 2022
Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infectionJennifer M Geris, Arianna L Stancari, Madeline R Meirhaeghe, et al.
Pageof 1